ArticleSA journal of radiology2026
Neuroendocrine neoplasms in uncommon gastrointestinal sites: A case series and literature review.
Article in SA journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroendocrine neoplasms (NENs) are rare, heterogeneous tumours arising from neuroendocrine cells located throughout the body. The gastrointestinal (GI) tract is the most frequent site of origin, but lesions in unusual locations such as the duodenum, gallbladder and rectum are diagnostically challenging because of their atypical presentation and radiological appearance. This series describes three patients with NENs at uncommon GI sites, highlighting imaging findings, histopathological features and management tailored to the tumour site and grade. Contribution: Although rare, NENs at uncommon GI sites should be included in the differential diagnosis of hypervascular lesions. Accurate diagnosis requires integration of cross-sectional imaging, somatostatin-receptor PET and immunohistochemistry, guiding individualised therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.